Inventionmed S.A.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-08-02
Share capital
20,278,715.60 PLN
Activity description

Inventionmed is an innovative Polish technology company that specializes in developing virtual reality medical simulators for education in clinical and aesthetic dermatology. Their flagship project, TutorDerm, is a simulator and application designed to facilitate the treatment of various dermatological conditions. The company utilizes a groundbreaking dual immersion technology that combines cyberspace with sensory perception to create realistic experiences in VR training.

Registered address
ul. Jana Zamoyskiego 2B, 85-063 Bydgoszcz, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-67343-48379-HRCSU-16

Financials

Revenue history (in k)

From the notes

Loans and borrowings$6,093,463

Filing timeliness

Financial statements were filed on time, on average 20 days early. All were audited by a statutory auditor.

  • 202503/07/2026
  • 202407/07/2025
  • 202308/07/2024
  • 202205/07/2023
  • 202115/07/2022
  • 202026/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.10
-0.01 (-5.48%)
0.100.110.110.110.1010:0012:0014:0016:00
Open
PLN 0.11
High
PLN 0.11
Low
PLN 0.10
Volume
169.95K
Avg. vol.
82.7K
Market cap
PLN 20.99M
P/E ratio
10.35
EPS
PLN 0.01
Shares outstanding
202.79M
52-week
PLN 0.10 – 0.11
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 0.01USD 32.07USD -625.11
Q1 2026USD 0.01USD 21.96USD -50.30
Q4 2025USD 0.01USD 13.50USD 37.79
Q3 2025USD 0.00USD -1.31USD 40.66

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Computer programming activities2,158 / 11,185
Top 19%
Sector · Information and communication3,708 / 21,361
Top 17%
City · Bydgoszcz874 / 3,083
Top 28%
Voivodeship · Kujawsko-Pomorskie3,721 / 11,436
Top 33%
Country · Poland90,371 / 297,069
Top 30%

Results vs industry

Revenue
This companyUSD 1.01mMedianUSD 120.70kAverageUSD 1.77m
Net profit
This companyUSD -326.37kMedianUSD 2.92kAverageUSD 23.76k
Operating costs
This companyUSD 904.30kMedianUSD 112.29kAverageUSD 1.69m
Assets
This companyUSD 9.78mMedianUSD 79.64kAverageUSD 1.14m

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2023.

MarkNumberClassesStatusProtected until
MED InventionMed Z.5573989, 41, 42Protected Jun 23, 2033
MarkProtected until
MED InventionMed Jun 23, 2033

Authorized Representatives

Tomasz Aleksander Kierul age 39 – President of the Management Board

Manner of representation

In the case of a one-person management board, one member of the management board is authorised to make declarations of will on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board acting jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Supervisory board

Barbara Zegarska age 72 – Supervisory Board Member
Kinga Elżbieta Kierul age 44 – Supervisory Board Member
Iwona Kierul age 38 – Supervisory Board Member
Jacek Suty age 53 – Supervisory Board Member
Jan Trzciński age 40 – Supervisory Board Member

Beneficial owners

Inventionmed is a public company listed on NewConnect, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Subsidiaries

NameStake
50%

Bank accounts

Registered as a VAT taxpayer on 2013-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$834.6K
Buildings and premises
$6M

Public aid

11 public aid cases recorded, with a total value of $4,762,124.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$808
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,234
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$14,748

European Funds

ProjectEU co-financing
Development of an innovative medical simulator using dual-immersion technology.
$458.8K
Center for innovative medical and rehabilitation simulation techniques based on virtual and augmented reality and proprietary dual-immersion technology.
$4.2M

Competitors

Name
Simmersiv sp. z o.o.
Wenkly Studio sp. z o.o.
Simart Center sp. z o.o.
Spectral Games S.A.
Carbon Studio S.A.
Flint Systems sp. z o.o.
Holo Vectors sp. z o.o.
Visus Vr sp. z o.o.
Raving Bots sp. z o.o.
Trusense sp. z o.o.

Change history

DateEvent
2020-11-30Address change
2020-10-09Share capital increase
2018-12-18Share capital reduction
2018-02-16Address change
2018-02-16Share capital increase

FAQ

Last updated: 2026-07-17